[Congressional Record Volume 164, Number 100 (Friday, June 15, 2018)]
[Daily Digest]
[Pages D682-D683]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]





                        House of Representatives


Chamber Action
Public Bills and Resolutions Introduced: 10 public bills, H.R. 6122-
6131; and 1 resolution, H. Res. 946 were introduced.         
  Page H5224
Additional Cosponsors:                                       
  Page H5225
Reports Filed: There were no reports filed today.
Speaker: Read a letter from the Speaker wherein he appointed 
Representative Bost to act as Speaker pro tempore for today. 
                                                             Page H5203
Journal: The House agreed to the Speaker's approval of the Journal by 
voice vote.                                          
  Pages H5203, H5221
Stop the Importation and Trafficking of Synthetic Analogues Act: The 
House passed H.R. 2851, to amend the Controlled Substances Act to 
clarify how controlled substance analogues are to be regulated, by a 
recorded vote of 239 ayes to 142 noes, Roll No. 268.     
  Pages H5204-21
  Pursuant to the Rule, it shall be in order to consider as an original 
bill for the purpose of amendment under the five-minute rule an 
amendment in the nature of a substitute consisting of the text of Rules 
Committee Print 115-74, in lieu of the amendment in the nature of a 
substitute recommended by the Committee on the Judiciary. 
                                                         Pages H5212-15
Agreed to:
  Griffith amendment (No. 1 printed in part A of H. Rept. 115-751) that 
incorporates an inter-agency agreement transmitted to Congress by the 
Office of National Drug Control Policy (ONDCP), the U.S. Department of 
Health and Human Services (HHS) and the U.S. Department of Justice 
(DOJ); clarifies when the Attorney General can temporarily and 
permanently schedule a drug or substance to the newly created schedule 
A and prevents the Attorney General from permanently scheduling that 
drug or substance if the Secretary of HHS determines that there is not 
sufficient potential for abuse; also clarifies under what circumstances 
an applicant for a schedule A registration may continue to conduct 
research with such schedule A substance while their application is 
pending, among their research accommodations;            
Pages H5215-16
  Jackson Lee amendment (No. 2 printed in part A of H. Rept. 115-751) 
that strikes sentencing commission provision;            
Pages H5216-17
  Sean Patrick Maloney (NY) amendment (No. 3 printed in part A of H. 
Rept. 115-751) that requires the Drug Enforcement Administration to 
make available a report on controlled substance analogues sold by means 
of the internet; and                                     
Pages H5217-18
  Thornberry amendment (No. 4 printed in part A of H. Rept. 115-751) 
that specifies the factors to determine whether a controlled substance 
analogue is intended for human consumption, thus making it easier for 
law enforcement and health officials to take action against synthetic 
drug manufacturers, distributors, and sellers (by a recorded vote of 
223 ayes to 158 noes, Roll No. 267).                     
Pages H5218-20
  H. Res. 934, the rule providing for consideration of the bills (H.R. 
2851), (H.R. 5735), and (H.R. 5788) was agreed to Wednesday, June 13th.
Meeting Hour: Agreed by unanimous consent that when the House adjourns 
today, it adjourn to meet at 12 noon on Tuesday, June 19th for Morning 
Hour debate.                                                 
  Page H5221

[[Page D683]]

Quorum Calls--Votes: Two recorded votes developed during the 
proceedings of today and appear on pages H5220 and H5221. There were no 
quorum calls.
Adjournment: The House met at 9 a.m. and adjourned at 11:38 a.m.